[1]
“Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer”, JOC, vol. 7, no. 1, Sep. 2008, Accessed: Dec. 07, 2025. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/204